What payment terms are accepted?

Accepted payment terms include LC, T/T, Western Union, and Money Gram.

Where is the manufacturer located?

The company is headquartered in Nanjing, Jiangsu, China.

Ot-6c Orthopedic Surgery Traction Frame

Name: Ot-6c Orthopedic Surgery Traction Frame
Brand: Perlong Medical Equipment Co., Ltd.
SKU: 1959760975

Jiangsu, ChinaPerlong Medical Equipment Co., Ltd.

US$676.22-1,601.57

1 Piece

Product profile

Customization

Available

Application

Orthopedic

Material

Steel

Model NO.

OT-6C

Feature

Reusable

Certification

ISO13485

Group

Adult

Length

1420±50mm

Width

765±50mm

Traction Device Horizontal Rotary

0-180°

Traction Distance mm

(0-200)+-10%

Traction Device Height Adjustment

Above 400

Transport Package

Wooden Case

Specification

ISO

Trademark

Perlong

Origin

China

HS Code

9000000000

Key features

ISO13485 Certified: Meets international quality standards for medical devices.

Reusable Design: Durable steel construction ensures long-term clinical use.

Wide Application: Ideal for orthopedic fracture and dislocation reduction.

Versatile Compatibility: Can be combined with various types of operating tables.

Global Supplier: Exported to over 140 nations with 15+ years experience.

Fast Lead Time: Average production time within 15 workdays.

Professional Support: Comprehensive technical support and logistics assistance.

Company profile

Perlong Medical Equipment Co., Ltd.

Jiangsu, China

Business Type: Manufacturer/Factory, Trading CompanyExport Year: 2003-09-09Nearest Port: Shanghai, NingboAverage Response Time: ≤15hTerms of Payment: LC, T/T, Western Union, etc.International Commercial Terms(Incoterms): FOB, EXW, CFR, CIF, DAT, FAS, DDP, DAP, CIP, CPT, Others, FCA

AI-Powered supplier vetting

SummaryPerlong Medical Equipment Co., Ltd. is a China-based limited company in Nanjing, Jiangsu, engaged in medical-equipment trade and manufacturing. The supplier states that it has operated since 2003, possesses self-operated import and export rights, and derives 90% of sales from exports. Its product scope includes patient monitors, anesthesia, X-ray, laboratory, ECG, ultrasound, dental, ventilator, and biochemistry equipment. ISO 13485 and ISO 9001 management certifications are reported, along with 11–20 R&D engineers, 11–20 quality-control staff, and three production lines. The company claims exports to more than 140 countries and cooperation with WHO, UNDP, and UNICEF, but these claims are not independently substantiated in the provided data. The available trade records show transactions involving buyers in Uzbekistan and Tanzania, including patient-monitor shipments. Evidence is insufficient to assess financial credibility, customization capability, or the full extent of after-sales support.

Supplier typeThe supplier is identified as both a trading company and manufacturer/factory, operating as a limited company in Nanjing, China, with medical equipment as its commercial focus. Its stated product range and company profile support classification as a medical-equipment supplier with combined trading and manufacturing activities.

CertificationsThe supplier reports ISO 13485 and ISO 9001 management-system certifications. It also states that most products have obtained ISO certifications and that some have met CE and FDA requirements, although the specific certified products and certificate details are not provided.

Production capacityThe company is described as a manufacturer/factory as well as a trading company, with three production lines, 11–20 quality-control staff, and a factory location in Nanjing. Its stated manufacturing role and operating resources support production capability, although product-specific capacity and utilization are not provided.

Client casesThe supplier claims cooperation with WHO, UNDP, and UNICEF and exports to more than 140 countries. The trade records additionally identify ООО BAYMED INNOVATION in Uzbekistan and KAIRUKI HOSPITAL in Tanzania, including patient-monitor transactions; these records demonstrate named transaction cases but do not independently validate the broader international-client claims.